Multimodal Imaging Analysis, SD-OCT and OCT Angiography, Retinal Variations Observed in Dialysis Patients (OCTADIAL)

Little knowledge exist on the short and long-term ophthalmological effect of the dialysis. Some studies stated a variation of the thickness subfoveal choroidal before and after a session of dialyse as well as variations of the coat of optical fibers measured in OCT.

The Optical Coherence Tomography angiography OCT is a not invasive imaging technique which is now a part of examinations of investigation in imaging of retina. This technique allows to study the retinal macula vascularization without injection of contrast agent and thus allows to deepen the knowledge in medical domains where the exploration was to limited because of the invasive character of the examinations.

The hypothesis of this project is that hemodynamic change during the hemodialysis may lead fine variations of the retinal vascularization in the short-term (the day of the dialysis) but also in the longer term (over 1 year).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Creteil, France, 94000
        • Ophtalmology department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients in hemodialysis.

Description

Inclusion Criteria:

  • Indication of treatment by hemodialysis
  • First session of dialysis
  • Hemodialysis planned for 1 minimum year

Exclusion Criteria:

  • particular ophthalmological Histories: vitreo-retinal surgery, strong nearsightedness, chronic glaucoma
  • Unaffiliated in a national insurance scheme

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
vascular density before hemodialysis
Time Frame: before hemodialysis
Analysis of the variation of the vascular densities in retinal macula in the central 6 mm
before hemodialysis
vascular density 1 hour after hemodialysis
Time Frame: 1 hour after hemodialysis
Analysis of the variation of the vascular densities in retinal macula in the central 6 mm
1 hour after hemodialysis

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
vascular density 1 month after dialysis
Time Frame: 1 month after dialysis
Analysis of the variation of the vascular densities in retinal macula in the central 6 mm
1 month after dialysis
vascular density 3 month after dialysis
Time Frame: 3 month after dialysis
Analysis of the variation of the vascular densities in retinal macula in the central 6 mm
3 month after dialysis
vascular density 6 month after dialysis
Time Frame: 6 month after dialysis
Analysis of the variation of the vascular densities in retinal macula in the central 6 mm
6 month after dialysis
vascular density 12 month after dialysis
Time Frame: 12 month after dialysis
Analysis of the variation of the vascular densities in retinal macula in the central 6 mm
12 month after dialysis
vascular density before dialysis
Time Frame: before dialysis
mesure by OCTA
before dialysis
vascular density 1 hour after dialysis
Time Frame: 1 hour after dialysis
mesure by OCTA
1 hour after dialysis
vascular density 1 month after dialysis
Time Frame: 1 month after dialysis
mesure by OCTA
1 month after dialysis
vascular density 3 month after dialysis
Time Frame: 3 month after dialysis
mesure by OCTA
3 month after dialysis
vascular density 6 month after dialysis
Time Frame: 6 month after dialysis
mesure by OCTA
6 month after dialysis
vascular density 12 month after dialysis
Time Frame: 12 month after dialysis
mesure by OCTA
12 month after dialysis
size of coat retinal optical fibers before dialysis
Time Frame: before dialysis
variation of the coat
before dialysis
size of coat retinal optical fibers 1 hour after dialysis
Time Frame: 1 hour after dialysis
variation of the coat
1 hour after dialysis
size of coat retinal optical fibers 1 month after dialysis
Time Frame: 1 month after dialysis
variation of the coat
1 month after dialysis
size of coat retinal optical fibers 3 month after dialysis
Time Frame: 3 month after dialysis
variation of the coat
3 month after dialysis
size of coat retinal optical fibers 6 month after dialysis
Time Frame: 6 month after dialysis
variation of the coat
6 month after dialysis
size of coat retinal optical fibers 12 month after dialysis
Time Frame: 12 month after dialysis
variation of the coat
12 month after dialysis

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

February 26, 2019

Study Completion (Actual)

June 1, 2020

Study Registration Dates

First Submitted

January 11, 2019

First Submitted That Met QC Criteria

January 11, 2019

First Posted (Actual)

January 15, 2019

Study Record Updates

Last Update Posted (Actual)

August 4, 2020

Last Update Submitted That Met QC Criteria

July 31, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • OCTADIAL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Renal Failure

Clinical Trials on Multimodal Imaging Analysis

Subscribe